VEGFA and neoplasm: Meyer et al. have reported on benefits of phosphodiesterase-5 (PDE5) inhibitor sildenafil to impact MDSCs function by decreasing secretion of ARG1, IL-1β, IL-6, and VEGF in tumour-bearing mice and thus improving their survival [61].